Skip to content
Diethylpropion
Tenuate, Tepanil (diethylpropion) is a small molecule pharmaceutical. Diethylpropion was first approved as Tepanil on 1982-01-01. It is used to treat obesity in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
nutritional and metabolic diseasesD009750
signs and symptoms pathological conditionsD013568
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Diethylpropion hydrochloride
Tradename
Company
Number
Date
Products
TEPANIL3MN-011673 DISCN1982-01-01
1 products
TEPANIL TEN-TAB3MN-017956 DISCN1982-01-01
1 products
TENUATENostrum LaboratoriesN-011722 DISCN1982-01-01
1 products, RLD
TENUATE DOSPANNostrum LaboratoriesN-012546 DISCN1982-01-01
1 products, RLD
TENUATESanofiN-017668 DISCN1982-01-01
1 products
TENUATESanofiN-017669 DISCN1982-01-01
1 products
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
diethylpropion hydrochlorideANDA2023-06-19
tepanil2006-07-26
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
obesityEFO_0001073D009765E66.9
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
A: Alimentary tract and metabolism drugs
A08: Antiobesity preparations, excl. diet products
A08A: Antiobesity preparations, excl. diet products
A08AA: Centrally acting antiobesity products
A08AA03: Amfepramone
HCPCS
No data
Clinical
Clinical Trials
13 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
LoiasisD008118B74.3112
InfectionsD007239EFO_000054411
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Filarial elephantiasisD004605EFO_0007272B74.03238
YawsD015001EFO_0007548A66112
TrachomaD014141A7111
ScabiesD012532B8611
StrongyloidiasisD013322EFO_0007501B7811
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Wounds and injuriesD014947T14.811
Indications Phases 1
No data
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Parasitic diseasesD010272EFO_0001067B8811
OnchocerciasisD009855EFO_0007402B7311
FilariasisD005368B7411
MansonelliasisD008368EFO_0007357B74.411
HelminthiasisD006373EFO_1001342B65-B8311
Hiv infectionsD015658EFO_0000764B2011
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameDIETHYLPROPION
INNamfepramone
Description
Diethylpropion is an aromatic ketone that is propiophenone in which one of the hydrogens alpha- to the carbonyl is substituted by a diethylamino group. A central stimulant and indirect-acting sympathomimetic, it is an appetite depressant and is used as the hydrochloride as an anoretic in the short term management of obesity. It has a role as an appetite depressant. It is a tertiary amine and an aromatic ketone. It is functionally related to a propiophenone.
Classification
Small molecule
Drug class
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CCN(CC)C(C)C(=O)c1ccccc1
Identifiers
PDB
CAS-ID90-84-6
RxCUI
ChEMBL IDCHEMBL1194666
ChEBI ID4530
PubChem CID7029
DrugBankDB00937
UNII IDQ94YYU22B8 (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 644 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
100 adverse events reported
View more details